Model Medicines
PrivateLast Round
Seed
Nov 14, 2025
Total Funding Raised
$4.1M
Company Overview
Model Medicines is a biotechnology company that develops AI-driven drug discovery platforms and therapeutics for oncology, infectious diseases, and other therapeutic areas.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Model Medicines Comparables
Compare Model Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Molecular AI | 87% | |
| Iambic Therapeutics | 83% | |
| Gandeeva Therapeutics | 78% |
Model Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 14, 2025 | ||||
| Accelerator | Jun 12, 2025 | ||||
| Accelerator | May 29, 2024 | ||||
| Seed | Nov 3, 2021 |
Key People
Founding team and executive leadership
Model Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nex Cubed | Seed |
| ParticleX | Seed |
| MedTech Innovator | Accelerator |
| Irving Investors | Seed |
| Public Health Emergency Medical Countermeasures Enterprise | Accelerator |
| BioTools Innovator | Accelerator |
| 8VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Monthly visitors increased 40% MoM.
- Mar 19, 2026
CEO to present at the Artificial Intelligence Convergence Summit in Boston.
Model Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Model Medicines's valuation, stock price, and market status.
Is Model Medicines a public or private company?
Model Medicines is a private company.
What is the current stock price of Model Medicines?
Model Medicines is a private company with no public stock price. No recent secondary market data is available.
How much is Model Medicines worth (valuation)?
Valuation information for Model Medicines is not publicly available.
Can I buy Model Medicines stock?
Model Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Model Medicines's last funding round?
Model Medicines's most recent funding round was Seed on November 14, 2025.
Who are the main investors in Model Medicines?
Key investors in Model Medicines include Nex Cubed, Irving Investors, BioTools Innovator, 8VC.
Will Model Medicines IPO soon?
No public IPO plans have been announced for Model Medicines.
How can I track Model Medicines secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Model Medicines's secondary market activity and sign up for updates.